Hexagon Nutrition
Hexagon Nutrition Limited, established in 1993, is a leading nutrition company in India. It focuses on developing and manufacturing micronutrient premix products, clinical nutrition, and therapeutic foods, serving both domestic and international markets.
Price Band
₹45 - ₹45
Lot Size
333 Shares
Issue Size
₹138.87 Cr
Fresh Issue
Nil (Pure OFS)
OFS
₹138.87 Cr (Full Issue)
Registrar
AI Sentiment Score
Listing Price
₹48.25
vs Issue: ₹45 (+7.22%)
📅 IPO Timeline
1
Open
TBD
2
Close
TBD
✓
Allotment
Jun 10
✓
Refund
Jun 11
✓
Demat
Jun 11
✓
Listing
Jun 12
✨ AI Analysis & Prediction
+4.8%
predicted listing gain
Hexagon Nutrition's IPO is characterized by a lack of institutional demand with a 0.0x QIB subscription, which negatively impacts the listing gain potential. However, the small float size and a modest grey market premium provide some support for a positive listing. The company's financials show steady growth, but the pure OFS structure and absence of fresh capital raise concerns.
💪 Strengths
- Established market presence
- Diverse product portfolio
⚠️ Weaknesses
- Pure OFS structure
- Lack of fresh capital
🚀 Opportunities
- Expansion in international markets
- Growing demand for nutrition products
🛡️ Threats
- Intense competition
- Regulatory challenges
📊 Key Financials
| Metric | 2023 | 2024 | 2025 | Dec 2025 |
|---|---|---|---|---|
| Revenue (₹ Cr) | 281.65 | 304.62 | 331.29 | 275.57 |
| PAT (₹ Cr) | 5.82 | 12.21 | 24.38 | 27.03 |
📋 Live Subscription Status
QIB
0.00x
NII
0.00x
Retail
0.00x
Total
0.00x
📈 Shareholding & Anchor Lock-In
🔗 Important Links & Lead Managers
- Check Allotment StatusCheck Now →
- Registrar WebsiteVisit →
- Download DRHP ProspectusDownload PDF 📥
- Download RHP ProspectusDownload PDF 📥
Lead Managers / Merchant Bankers
This issue is managed by Hem Securities Ltd., and Share India Capital Services Pvt. Ltd.
Disclaimer: The information provided on this page is for educational and informational purposes only and does not constitute financial advice. IPO investments are subject to market risks. AI-generated analysis is based on publicly available data and may not be accurate. Grey Market Premium (GMP) is unofficial and highly speculative. Always consult a qualified financial advisor and read the DRHP/RHP carefully before making investment decisions.
Hexagon Nutrition Limited, founded in 1993, has established itself as a prominent player in the nutrition industry in India. The company operates across three key verticals: Micronutrient Premix Products, Clinical Nutrition, and Therapeutic Foods. These products are manufactured in three facilities located in Nasik, Chennai, and Thoothukudi, with an additional international facility in Tashkent, Uzbekistan. Hexagon Nutrition's product portfolio is diverse, catering to both B2C and B2B2C markets, and includes branded wellness and clinical nutrition products, premix formulations, and ready-to-use foods. The company has a robust distribution network with 342 distributors in India and exports to over 75 countries across Asia, Africa, Europe, and South America. The promoters, Arun Purushottam Kelkar, Subhash Purushottam Kelkar, Vikram Arun Kelkar, and Nikhil Arun Kelkar, have played a significant role in steering the company towards growth and expansion.
Hexagon Nutrition's IPO aims to raise approximately ₹138.87 crores through a book-built issue, with a price band set between ₹42 and ₹45 per share. The IPO comprises an offer for sale of up to 3,08,59,704 equity shares, with no fresh issue component. The IPO opens on June 5, 2026, and closes on June 9, 2026, with listing scheduled on June 12, 2026, on both BSE and NSE. The company's financial performance has shown a steady increase in revenue from ₹281.65 crores in 2023 to ₹331.29 crores in 2025, with a corresponding rise in PAT from ₹5.82 crores to ₹24.38 crores. Despite these positive trends, the IPO is purely an OFS, which raises concerns about the lack of fresh capital for growth. The company's P/E ratio and valuation compared to peers like Zydus Wellness and Nestlé India suggest a cautious approach. Key strengths include a strong market presence and diversified product portfolio, while risks involve the pure OFS structure and the absence of institutional demand. Investors are advised to consider these factors carefully before making investment decisions.